Charu Aggarwal, MD, MPH

Marmarelis ME, Gilligan AM, Sugihara T, Marquart T, Whipple S, Wang Y, Allen-Coyle TJ, Bhandari NR, Aggarwal C. The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC , Cancers (Basel), 18: 2026,2287

Meyer ML, Peters S, Borghaei H, Cascone T, Dacic S, Faivre-Finn C, Leighl N, Paz-Ares L, Aerts J, Aggarwal C, Ahn MJ, Arcila ME, Ardizzoni A, Arrieta O, Awad MM, Bar J, Barlesi F, Bazhenova L, Besse B, Chaft J, Cho BC, Curioni Fontecedro A, DE Ruysscher D, Dingemans AM, Dziadziuszko R, Felip E, Forde P, Gandara DR, Garassino MC, Garcia Campelo R, Garrido Lopez P, Gautschi O, Girard N, Goto Y, Gray J, Hendriks L, Hirsch F, Hui R, Janne PA, Kerr K, Khorshid O, Pechoux CLE, Leal T, Lin JJ, Linardou H, Liu S, Mahrous M, Malapelle U, Mercadante E, Mitsudomi T, Mok T, Mountzios G, Naidoo J, Normanno N, Novello S, Oliveira J, Pappagallo G, Perrone G, Pérol M, Raez LE, Ramella S, Rami-Porta R, Reckamp K, Reguart Aransay N, Remon Masip J, Ricardi U, Ricciuti B, Rodriguez-Abreu D, Rotow JK, Santos ES, Schalper K, Senan S, Seto T, Skoulidis F, Smit EF, Soares M, Solli P, Solomon B, Soo RA, Stahel R, Stiles BM, VAN Schil P, Veronesi G, Wistuba II, Wolf J, Wu YL, Zer A, Rolfo C, Landi L, Cappuzzo F. Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC , J Thorac Oncol: 2026

Barsouk AA, Yaskolko M, Sussman JH, Sun L, Singh AP, Cohen RB, Aggarwal C, Marmarelis ME, Langer CJ. Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC , Clin Lung Cancer, 27: 2026,50-55

Reisenauer JS, DiBardino DM, Criner GJ, Hunt SJ, Panaro J, Friedberg J, Mansfield AS, Aggarwal C, Bodor JN, Callstrom MR. Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case series , J Thorac Dis, 18: 2026,669

Adam Barsouk, Maxim Yaskolko, Jonathan H. Sussman, Lova Sun, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Melina E. Marmarelis Sotorasib vs adagrasib in the 2L+ setting: Outcomes in a large, multi-institutional, real-world database of KRAS-G12C mutated mNSCLC. , J Clin Oncol: 2026

Bleiberg BA, Scholes DG, Reed-Guy L, Dravid D, Sun LL, Singh AP, Cohen RB, Langer CJ, Marmarelis ME, Aggarwal C. Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461] , J Liq Biopsy, 12: 2026,100472

Phurin Areesawangkit, Adam Barsouk, Maxim Yaskolko, Lucy Wang, Cole Friedes, Roger B. Cohen, Lova Sun, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Steven J. Feigenberg, Jeffrey D. Bradley, Nikhil Yegya-Raman, Michelle Iocolano, Christiana Davis, Corey J. Langer Long-term survival outcomes of consolidative local ablative therapy after response to first-line systemic treatment in oligometastatic NSCLC. , J Clin Oncol: 2026

Michelle A. Worst, Andrew Small, Amy Furedy, Charu Aggarwal, Sandip P. Patel The impact of online CME on addressing clinical decision-making for immunotherapy in advanced squamous NSCLC. , J Clin Oncol: 2026

Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026

Rachel Jaber Chehayeb, Willdragon Wang, Lova Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Charu Aggarwal, Melina E. Marmarelis Incidentally discovered lung cancer in explanted lungs at the time of lung transplantation: Management and outcomes. , J Clin Oncol: 2026